MACO1

gene
On this page

Also known as FLJ10747

Summary

MACO1 (macoilin 1, HGNC:25572) is a protein-coding gene on chromosome 1p36.11, encoding Macoilin (Q8N5G2). Plays a role in the regulation of neuronal activity.

Predicted to enable microtubule binding activity. Involved in neuronal signal transduction. Located in rough endoplasmic reticulum membrane.

Source: NCBI Gene 55219 — RefSeq curated summary.

At a glance

  • GWAS associations: 22
  • Clinical variants (ClinVar): 65 total
  • Druggable target: yes
  • MANE Select transcript: NM_018202

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:25572
Approved symbolMACO1
Namemacoilin 1
Location1p36.11
Locus typegene with protein product
StatusApproved
AliasesFLJ10747
Ensembl geneENSG00000204178
Ensembl biotypeprotein_coding
OMIM610301
Entrez55219

Gene structure

Transcript identifiers

Ensembl transcripts: 10 — 8 protein_coding, 1 protein_coding_CDS_not_defined, 1 nonsense_mediated_decay

ENST00000374343, ENST00000399766, ENST00000470035, ENST00000647928, ENST00000897263, ENST00000897264, ENST00000897265, ENST00000897266, ENST00000897267, ENST00000897268

RefSeq mRNA: 2 — MANE Select: NM_018202 NM_001282564, NM_018202

CCDS: CCDS30638, CCDS60034

Canonical transcript exons

ENST00000374343 — 11 exons

ExonStartEnd
ENSE000014632142549826425500209
ENSE000014632162549141025491584
ENSE000014632172548917325489293
ENSE000014632192548561325485795
ENSE000014632202548411625484274
ENSE000014632232545839125458892
ENSE000014632242545665325456831
ENSE000014632282544880825448934
ENSE000014632302544676225446903
ENSE000019387112543089725431178
ENSE000035737672545425925454382

Expression profiles

Bgee: expression breadth ubiquitous, 269 present calls, max score 94.82.

FANTOM5 (CAGE): breadth ubiquitous, TPM avg 17.2602 / max 314.7606, expressed in 1810 samples.

FANTOM5 promoters (5 alternative TSS)

Promoter IDTPM avgSamples expressed
150211.14011788
15034.64351636
15040.7432383
15050.5981265
15010.135227

Top tissues by expression

283 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
cortical plateUBERON:000534394.82gold quality
tendon of biceps brachiiUBERON:000818893.63gold quality
lower esophagus mucosaUBERON:003583492.57gold quality
ganglionic eminenceUBERON:000402392.27gold quality
buccal mucosa cellCL:000233692.14gold quality
skeletal muscle tissue of biceps brachiiUBERON:000450290.98gold quality
body of pancreasUBERON:000115090.62gold quality
gastrocnemiusUBERON:000138889.97gold quality
tendonUBERON:000004389.87gold quality
islet of LangerhansUBERON:000000689.86gold quality
muscle of legUBERON:000138389.63gold quality
hindlimb stylopod muscleUBERON:000425289.42gold quality
calcaneal tendonUBERON:000370189.16gold quality
biceps brachiiUBERON:000150788.96gold quality
pancreasUBERON:000126488.84gold quality
liverUBERON:000210788.39gold quality
cerebellar cortexUBERON:000212988.13gold quality
cerebellar hemisphereUBERON:000224588.11gold quality
right lobe of liverUBERON:000111488.08gold quality
muscle organUBERON:000163087.69gold quality
cerebellumUBERON:000203787.63gold quality
right adrenal gland cortexUBERON:003582786.96gold quality
right hemisphere of cerebellumUBERON:001489086.79gold quality
adrenal tissueUBERON:001830386.73gold quality
male germ line stem cell (sensu Vertebrata) in testisCL:0000089 ∩ UBERON:000047386.60gold quality
left adrenal glandUBERON:000123486.51gold quality
adrenal glandUBERON:000236986.16gold quality
right adrenal glandUBERON:000123386.05gold quality
left adrenal gland cortexUBERON:003582586.01gold quality
esophagus mucosaUBERON:000246985.90gold quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 1.

ExperimentMarker?Max mean expression
E-ANND-3yes6.45

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

106 targeting MACO1, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-3646100.0073.565283
HSA-MIR-3613-3P100.0076.367965
HSA-MIR-371B-5P99.9975.344759
HSA-MIR-428299.9975.366408
HSA-MIR-548C-3P99.9974.017587
HSA-MIR-616-5P99.9875.584775
HSA-MIR-373-5P99.9875.364753
HSA-MIR-477599.9875.006394
HSA-MIR-548P99.9872.253784
HSA-MIR-50799.9770.111915
HSA-MIR-314899.9775.066478
HSA-MIR-548AN99.9770.912817
HSA-MIR-55799.9670.011640
HSA-MIR-365899.9673.874379
HSA-MIR-495-3P99.9672.814197
HSA-MIR-568899.9673.234504
HSA-MIR-548AJ-3P99.9673.385345
HSA-MIR-548X-3P99.9673.385345
HSA-MIR-1468-3P99.9672.743797
HSA-MIR-545-3P99.9570.742783
HSA-MIR-548J-3P99.9472.614881
HSA-MIR-548AE-3P99.9372.664867
HSA-MIR-548AH-3P99.9372.544872
HSA-MIR-548AM-3P99.9372.544872
HSA-MIR-548AQ-3P99.9372.664867
HSA-MIR-450B-5P99.9271.483175
HSA-MIR-368699.9070.532432
HSA-MIR-627-3P99.9071.423316
HSA-MIR-449699.8868.892236
HSA-MIR-548D-3P99.8770.674362

Literature-anchored findings (GeneRIF, showing 1)

  • these results indicate that PAK4 confers CDDP resistance via the activation of MEK/ERK and PI3K/Akt pathways. PAK4 and PI3K/Akt pathways can reciprocally activate each other. (PMID:27919029)

Cross-species orthologs

6 orthologs

OrganismSymbolGene ID
danio_reriosi:dkey-12h9.6ENSDARG00000056092
mus_musculusMaco1ENSMUSG00000028826
rattus_norvegicusMaco1ENSRNOG00000056156
drosophila_melanogasterbifFBGN0014133
drosophila_melanogasterCG30389FBGN0050389
caenorhabditis_elegansmaco-1WBGENE00017066

Protein

Protein identifiers

MacoilinQ8N5G2 (reviewed: Q8N5G2)

Alternative names: Macoilin-1, Transmembrane protein 57

All UniProt accessions (2): A0A3B3ITD2, Q8N5G2

UniProt curated annotations — full annotation on UniProt →

Function. Plays a role in the regulation of neuronal activity.

Subcellular location. Nucleus membrane. Cell projection. Axon. Rough endoplasmic reticulum membrane.

Similarity. Belongs to the macoilin family.

Isoforms (3)

UniProt IDNamesCanonical?
Q8N5G2-11yes
Q8N5G2-22
Q8N5G2-33

RefSeq proteins (2): NP_001269493, NP_060672* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR019130MacoilinFamily

Pfam: PF09726

UniProt features (22 total): transmembrane region 4, modified residue 4, glycosylation site 4, splice variant 3, region of interest 3, compositionally biased region 2, chain 1, sequence conflict 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q8N5G2-F166.840.30

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Post-translational modifications (4): 305, 332, 631, 634

Glycosylation sites (4): 324, 340, 452, 655

Function

Pathways and Gene Ontology

Reactome pathways

6 pathways

IDPathway
R-HSA-8980692RHOA GTPase cycle
R-HSA-9013106RHOC GTPase cycle
R-HSA-162582Signal Transduction
R-HSA-194315Signaling by Rho GTPases
R-HSA-9012999RHO GTPase cycle
R-HSA-9716542Signaling by Rho GTPases, Miro GTPases and RHOBTB3

MSigDB gene sets: 206 (showing top): FREAC2_01, MAZ_Q6, MEF2_02, GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_UP, GOBP_TAXIS, CATRRAGC_UNKNOWN, SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN, SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_DN, CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_5, HIF1_Q3, NRF2_Q4, GOBP_HEAD_DEVELOPMENT, ATF4_Q2, AACTTT_UNKNOWN, P300_01

GO Biological Process (3): chemotaxis (GO:0006935), brain development (GO:0007420), neuronal signal transduction (GO:0023041)

GO Molecular Function (3): microtubule binding (GO:0008017), molecular_function (GO:0003674), protein binding (GO:0005515)

GO Cellular Component (10): nucleus (GO:0005634), axon (GO:0030424), rough endoplasmic reticulum membrane (GO:0030867), nuclear membrane (GO:0031965), neuron projection terminus (GO:0044306), synapse (GO:0045202), endoplasmic reticulum (GO:0005783), membrane (GO:0016020), cell projection (GO:0042995), neuron projection (GO:0043005)

Reactome top-level categories

Rollup of top-4 pathways:

CategoryPathways
RHO GTPase cycle2
Signaling by Rho GTPases, Miro GTPases and RHOBTB31
Signaling by Rho GTPases1
Signal Transduction1

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
cellular anatomical structure3
intracellular membrane-bounded organelle2
neuron projection2
response to chemical1
taxis1
central nervous system development1
animal organ development1
head development1
signal transduction1
tubulin binding1
binding1
endoplasmic reticulum membrane1
rough endoplasmic reticulum1
bounding membrane of organelle1
nucleus1
nuclear envelope1
organelle membrane1
cell junction1
cytoplasm1
endomembrane system1
plasma membrane bounded cell projection1

Protein interactions and networks

STRING

662 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
MACO1SYN1P17600744
MACO1RSRP1Q9BUV0659
MACO1TMEM50AO95807547
MACO1RHCEP18577545
MACO1YPEL4Q96NS1499
MACO1SYF2O95926493
MACO1RIC3Q7Z5B4484
MACO1MEMO1Q9Y316446
MACO1DEDD2Q8WXF8439
MACO1MYBPHLA2RUH7422
MACO1CTCFP49711417
MACO1GALNT5Q7Z7M9414
MACO1UBL4BQ8N7F7412
MACO1RANBP10Q6VN20411
MACO1TBC1D15Q8TC07401

IntAct

173 interactions, top by confidence:

ABTypeScore
CFTRESYT2psi-mi:“MI:2364”(proximity)0.710
MACO1CCN3psi-mi:“MI:0915”(physical association)0.560
MACO1POTEB3psi-mi:“MI:0915”(physical association)0.560
MACO1MEI4psi-mi:“MI:0915”(physical association)0.560
LCE2CMACO1psi-mi:“MI:0915”(physical association)0.560
CCN3MACO1psi-mi:“MI:0915”(physical association)0.560
KRTAP5-7MACO1psi-mi:“MI:0915”(physical association)0.560
MACO1CRCT1psi-mi:“MI:0915”(physical association)0.560
LCE1DMACO1psi-mi:“MI:0915”(physical association)0.560
KRTAP5-2MACO1psi-mi:“MI:0915”(physical association)0.560
NOTCH2NLCMACO1psi-mi:“MI:0915”(physical association)0.560
LCE1EMACO1psi-mi:“MI:0915”(physical association)0.560
MEOX2MACO1psi-mi:“MI:0915”(physical association)0.560
LCE1FMACO1psi-mi:“MI:0915”(physical association)0.560
LCE3AMACO1psi-mi:“MI:0915”(physical association)0.560
MACO1TMEM190psi-mi:“MI:0915”(physical association)0.560
LCE3EMACO1psi-mi:“MI:0915”(physical association)0.560
HOXA1MACO1psi-mi:“MI:0915”(physical association)0.560
MACO1LINGO1psi-mi:“MI:0915”(physical association)0.560
SMCPMACO1psi-mi:“MI:0915”(physical association)0.560
LCE1CMACO1psi-mi:“MI:0915”(physical association)0.560
POTEB3MACO1psi-mi:“MI:0915”(physical association)0.560
MACO1ZNF655psi-mi:“MI:0915”(physical association)0.560
MACO1NR4A3psi-mi:“MI:0915”(physical association)0.560
MEI4MACO1psi-mi:“MI:0915”(physical association)0.560
PCDHAC2TMEM223psi-mi:“MI:0914”(association)0.530

BioGRID (250): TMEM57 (Affinity Capture-MS), TMEM57 (Affinity Capture-MS), TMEM57 (Affinity Capture-MS), TMEM57 (Biochemical Activity), TMEM57 (Proximity Label-MS), TMEM57 (Proximity Label-MS), TMEM57 (Proximity Label-MS), TMEM57 (Affinity Capture-MS), TMEM57 (Affinity Capture-MS), TMEM57 (Affinity Capture-MS), TMEM57 (Affinity Capture-MS), TMEM57 (Affinity Capture-MS), TMEM57 (Affinity Capture-MS), TMEM57 (Proximity Label-MS), TMEM57 (Affinity Capture-MS)

ESM2 similar proteins: A1Z7Z9, A9UM82, G5EEK3, O14490, P11929, P97836, Q15007, Q2KN93, Q2KN94, Q2KN95, Q2KN96, Q2KN97, Q2KN98, Q2KN99, Q2KNA0, Q2KNA1, Q2TLY1, Q2TLY2, Q2TLZ1, Q2TLZ2, Q2TLZ3, Q2TLZ4, Q2TLZ5, Q3UIJ9, Q4KLT6, Q4V7D3, Q5EB94, Q5M775, Q5NVC2, Q5SXY1, Q60JJ0, Q60MF5, Q69YQ0, Q6P4K5, Q7SXL7, Q7TQE6, Q7YZA2, Q86W92, Q8C8U0, Q8N5G2

Diamond homologs: P91193, Q2TLY1, Q2TLY2, Q2TLZ1, Q2TLZ2, Q2TLZ3, Q2TLZ4, Q2TLZ5, Q4V7D3, Q7TQE6, Q8N5G2

SIGNOR signaling

0 interactions.

Enriched among interaction partners

Reactome pathways and GO biological processes over-represented among this gene’s 165 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.

Reactome pathways:

PathwayPartnersFoldFDR
Formation of the cornified envelope76.8×9e-03
Keratinization95.5×6e-03

GO biological processes:

GO termPartnersFoldFDR
keratinization712.6×1e-03

Disease & clinical

Clinical variants and AI predictions

ClinVar

65 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance48
Likely benign1
Benign0

Top pathogenic / likely-pathogenic (0)

SpliceAI

2004 predictions. Top by Δscore:

VariantEffectΔscore
1:25431176:CAGGT:Cdonor_loss1.0000
1:25431177:AGGT:Adonor_loss1.0000
1:25431179:G:GCdonor_loss1.0000
1:25431180:T:Gdonor_loss1.0000
1:25446760:A:AGacceptor_gain1.0000
1:25446761:G:GGacceptor_gain1.0000
1:25446761:GT:Gacceptor_gain1.0000
1:25446761:GTAC:Gacceptor_gain1.0000
1:25454257:A:AGacceptor_gain1.0000
1:25454258:G:GGacceptor_gain1.0000
1:25454258:GAAA:Gacceptor_gain1.0000
1:25456651:A:AGacceptor_gain1.0000
1:25456652:G:GGacceptor_gain1.0000
1:25456652:GT:Gacceptor_gain1.0000
1:25456652:GTAT:Gacceptor_gain1.0000
1:25456652:GTATT:Gacceptor_gain1.0000
1:25484112:CTA:Cacceptor_loss1.0000
1:25484114:A:ACacceptor_loss1.0000
1:25484114:A:AGacceptor_gain1.0000
1:25484114:AGGCT:Aacceptor_gain1.0000
1:25484115:G:GAacceptor_loss1.0000
1:25484115:G:GGacceptor_gain1.0000
1:25484115:GGCTG:Gacceptor_gain1.0000
1:25484270:AACAA:Adonor_gain1.0000
1:25484271:ACAA:Adonor_gain1.0000
1:25484272:CAA:Cdonor_gain1.0000
1:25484273:AA:Adonor_gain1.0000
1:25484274:AG:Adonor_loss1.0000
1:25484275:G:Cdonor_loss1.0000
1:25484275:G:GGdonor_gain1.0000

AlphaMissense

4409 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
1:25431135:C:AR13S1.000
1:25446793:T:AW38R1.000
1:25446793:T:CW38R1.000
1:25446814:G:CD45H1.000
1:25446833:G:CR51T1.000
1:25446833:G:TR51I1.000
1:25446847:T:AW56R1.000
1:25446847:T:CW56R1.000
1:25446860:T:CL60P1.000
1:25448880:T:AW99R1.000
1:25448880:T:CW99R1.000
1:25448893:C:AA103D1.000
1:25448896:C:AA104D1.000
1:25448898:A:CS105R1.000
1:25448900:C:AS105R1.000
1:25448900:C:GS105R1.000
1:25448910:T:AW109R1.000
1:25448910:T:CW109R1.000
1:25454291:T:AW128R1.000
1:25454291:T:CW128R1.000
1:25454373:C:AA155D1.000
1:25454376:C:AA156D1.000
1:25456657:G:AG160R1.000
1:25456657:G:CG160R1.000
1:25456657:G:TG160W1.000
1:25456658:G:AG160E1.000
1:25456749:C:AN190K1.000
1:25456749:C:GN190K1.000
1:25456766:T:CL196P1.000
1:25456769:T:CL197P1.000

dbSNP variants (sampled 300 via entrez): RS1000027457 (1:25473387 T>C), RS1000035283 (1:25453247 C>T), RS1000119056 (1:25487758 C>G,T), RS1000136193 (1:25453771 T>A), RS1000141693 (1:25466704 A>G), RS1000178436 (1:25477810 C>T), RS1000188058 (1:25435334 A>G), RS1000204440 (1:25487430 G>A), RS1000251887 (1:25478061 A>T), RS1000280780 (1:25494142 G>A,T), RS1000298179 (1:25439253 A>G), RS1000357654 (1:25479796 T>A), RS1000392691 (1:25439419 A>G), RS1000415051 (1:25484631 A>G), RS1000481582 (1:25435779 G>A)

Disease associations

OMIM: gene MIM:610301 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

22 associations (top):

StudyTraitp-value
GCST000285_9Cholesterol, total5.000000e-10
GCST000759_33LDL cholesterol1.000000e-10
GCST000760_48Cholesterol, total4.000000e-11
GCST001120_4Erythrocyte sedimentation rate5.000000e-13
GCST006612_48LDL cholesterol6.000000e-12
GCST006614_112Total cholesterol levels6.000000e-11
GCST008077_22LDL cholesterol levels3.000000e-07
GCST008077_69LDL cholesterol levels3.000000e-09
GCST008078_10LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df)8.000000e-16
GCST008078_69LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df)9.000000e-21
GCST008079_144LDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df)9.000000e-20
GCST008079_15LDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df)3.000000e-16
GCST008086_41LDL cholesterol levels in current drinkers5.000000e-11
GCST008086_55LDL cholesterol levels in current drinkers8.000000e-13
GCST009366_56LDL cholesterol levels x long total sleep time interaction (2df test)1.000000e-12
GCST010204_95Low density lipoprotein cholesterol levels4.000000e-36
GCST010243_184Apolipoprotein B levels4.000000e-42
GCST010245_195LDL cholesterol levels2.000000e-35
GCST011347_1Low density lipoprotein cholesterol levels5.000000e-09
GCST90002387_193Immature fraction of reticulocytes1.000000e-55
GCST90002396_120Mean reticulocyte volume2.000000e-17
GCST90002397_620Mean spheric corpuscular volume7.000000e-24

EFO canonical traits (5, from GWAS)

EFO IDTrait name
EFO:0004574total cholesterol measurement
EFO:0004611low density lipoprotein cholesterol measurement
EFO:0004329alcohol drinking
EFO:0004615apolipoprotein B measurement
EFO:0010701mean reticulocyte volume

Drugs & pharmacology

Drug and pharmacology data

Is drug target: yes

ChEMBL targets (1): CHEMBL6067170 (SINGLE PROTEIN)

PharmGKB: 1 entry (VIP=true, CPIC=false)

PharmGKB variants

1 variants.

VariantGenesLevelScore#Clin annotsDrugs
rs10903129MACO10.000

ChEMBL bioactivities

2 potent at pChembl≥5 of 2 total, top 2 by pChembl (potency: 10 = 0.1 nM, 6 = 1 µM).

pChemblTypeValueUnitMolecule
7.07Kd84.92nMCHEMBL3752910
7.04ED5091.96nMCHEMBL3752910

PubChem BioAssay actives

1 with measured affinity, of 2 total; 1 most potent distinct compounds. Largely complementary to BindingDB; screening values are coarse (µM, 4 dp), so sub-nM hits tie at the floor.

CompoundAssayTypeValueUnit
4-methyl-3-[(1-methyl-6-pyridin-3-ylpyrazolo[3,4-d]pyrimidin-4-yl)amino]-N-[3-(trifluoromethyl)phenyl]benzamide2149955: Binding affinity to human TMEM57 incubated for 45 mins by Kinobead based pull down assaykd0.0849uM

CTD chemical–gene interactions

37 total (human), top 30 by PubMed support.

ChemicalActions (top 5)PubMed papers
sodium arsenitedecreases expression, increases expression3
Valproic Acidaffects expression, decreases methylation2
Cyclosporineincreases expression2
GSK-J4increases expression1
FR900359decreases phosphorylation1
aminomethylphosphonic acid (AMPA)increases expression1
methylmercuric chloridedecreases expression1
lasiocarpinedecreases expression1
bisphenol Aaffects cotreatment, increases methylation1
beta-methylcholineaffects expression1
perfluorooctane sulfonic acidincreases expression1
(4-amino-1,4-dihydro-3-(2-pyridyl)-5-thioxo-1,2,4-triazole)copper(II)increases expression1
Sunitinibincreases expression1
Fulvestrantaffects cotreatment, increases methylation1
Glyphosateincreases expression1
Atrazineincreases expression1
Vehicle Emissionsincreases abundance, increases expression1
Benzo(a)pyreneincreases methylation1
Caffeineaffects phosphorylation1
Calcitriolincreases expression1
Demecolcineincreases expression1
Drugs, Chinese Herbalincreases expression1
Ethyl Methanesulfonateincreases expression1
Formaldehydeincreases expression1
Methyl Methanesulfonateincreases expression1
Naledaffects expression1
Naphthoquinonesincreases expression1
Thiramincreases expression1
Tobacco Smoke Pollutionincreases expression1
Tunicamycinincreases expression1

ChEMBL screening assays

1 unique, capped per target: 1 binding

Representative assays (with source publication via chembl_document):

Assay IDTypeDescriptionSource paper
CHEMBL5652997BindingBinding affinity to human TMEM57 incubated for 45 mins by Kinobead based pull down assayNVP-BHG712: Effects of Regioisomers on the Affinity and Selectivity toward the EPHrin Family. — ChemMedChem

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.